Nutritional Management of Type 2 Diabetes Mellitus and Obesity and Pharmacologic Therapies to Facilitate Weight Loss

被引:8
|
作者
Vetter, Marion L. [1 ,2 ]
Amaro, Anastassia [2 ]
Volger, Sheri [2 ,3 ]
机构
[1] Hosp Univ Penn, Ctr Weight & Eating Disorders, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Hosp Univ Penn, Div Endocrinol Diabet & Metab, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA
[3] Nestle SA, Wyeth Nutr, King Of Prussia, PA USA
关键词
medical nutrition therapy; pharmacotherapy; diabetes; obesity; LIFE-STYLE INTERVENTION; CORONARY-HEART-DISEASE; LOW-GLYCEMIC-INDEX; LOW-CARBOHYDRATE DIET; LOW-FAT DIET; CARDIOVASCULAR RISK-FACTORS; FOLLOW-UP; SWEETENED BEVERAGES; INSULIN SENSITIVITY; MEDITERRANEAN DIET;
D O I
10.3810/pgm.2014.01.2734
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diet plays an integral role in the treatment of type 2 diabetes mellitus (T2DM). Unfortunately, many patients with T2DM do not have access to a registered dietitian or certified diabetes educator, and rates of physician counseling about diet remain low. This article provides an overview of the current recommendations for the nutritional management of T2DM, which are endorsed by the American Diabetes Association (ADA). Medical nutrition therapy, which provides a flexible and individualized approach to diet, emphasizes the total number (rather than the type) of carbohydrate consumed. Because fat intake also affects glycemia and cardiovascular risk, a reduction in daily mono- and polyunsaturated fat intake is recommended for most patients with T2DM. Weight loss plays an important adjunct role in treating patients with T2DM, because the majority of individuals with T2DM are overweight or obese. Patient lifestyle modification, which encompasses diet, physical activity, and behavioral therapy, can be used to facilitate weight loss in conjunction with several different dietary approaches. These include low-carbohydrate, low-fat, low-glycemic index, and Mediterranean diets. Studies have demonstrated that modest weight loss (5%-10% of body weight) is associated with significant improvements in patient measures of glycemic control, lipids, blood pressure, and other cardiovascular risk factors. Furthermore, a modest weight loss of as little as 4.5 kg can result in reducing the glycated hemoglobin level by approximately 0.5%. Pharmacologic agents, when combined with these approaches, may further augment weight loss. Familiarity with these principles can help physicians provide dietary counseling to their patients with T2DM and obesity.
引用
收藏
页码:139 / 152
页数:14
相关论文
共 50 条
  • [1] Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies
    Thrasher, James
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2017, 120 (01): : S4 - S16
  • [2] Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies
    Thrasher, James
    [J]. AMERICAN JOURNAL OF MEDICINE, 2017, 130 (06): : S4 - S17
  • [3] Diabetes mellitus Type 2, obesity and weight loss
    Tremble, J
    Donaldson, D
    [J]. JOURNAL OF THE ROYAL SOCIETY FOR THE PROMOTION OF HEALTH, 1999, 119 (02): : 73 - 75
  • [4] Combination weight-loss therapies for type 2 diabetes mellitus
    Raatz, SK
    Redmon, JB
    Reck, KP
    Swanson, JE
    Kwong, CA
    Thomas, W
    Bantle, JP
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 : S145 - S145
  • [5] A combination of weight loss therapies for overweight subjects with type 2 diabetes mellitus
    Raatz, S
    Reck, K
    Kwong, C
    Redmon, JB
    Swanson, J
    Fan, Q
    Thomas, W
    Bantle, JP
    [J]. DIABETES, 2002, 51 : A413 - A414
  • [6] Benefits of Modest Weight Loss on the Management of Type 2 Diabetes Mellitus
    Lau, David C. W.
    Teoh, Hwee
    [J]. CANADIAN JOURNAL OF DIABETES, 2013, 37 (02) : 128 - 134
  • [7] New and Emerging Pharmacologic Therapies for Type 2 Diabetes, Dyslipidemia, and Obesity
    Taylor, James R.
    Dietrich, Eric
    Powell, Jason G.
    [J]. CLINICAL THERAPEUTICS, 2013, 35 (01) : A3 - A17
  • [8] Pharmacologic induction of weight loss to treat type 2 diabetes
    Redmon, JB
    Raatz, SK
    Kwong, CA
    Swanson, JE
    Thomas, W
    Bantle, JP
    [J]. DIABETES CARE, 1999, 22 (06) : 896 - 903
  • [9] Pharmacologic induction of weight loss to treat type 2 diabetes
    Bantle, J
    Raatz, S
    Kwong, C
    Swanson, J
    Hoover, B
    Thomas, W
    Redmon, B
    [J]. DIABETES, 1998, 47 : A104 - A104
  • [10] Pharmacologic Management of the Older Patient With Type 2 Diabetes Mellitus
    Neumiller, Joshua J.
    Setter, Stephen M.
    [J]. AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY, 2009, 7 (06): : 324 - 342